Hamilton Capital, LLC Amgen Inc Transaction History

Hamilton Capital, LLC

$1.37 Billion
Q3 2024

A detailed history of Hamilton Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Hamilton Capital, LLC holds 2,051 shares of AMGN stock, worth $602,994. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,051

Previous 2,027 1.18%

Holding current value

$602,994

Previous $633,000 4.27%

% of portfolio

0.05%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$309.38 - $337.38 $7,425 - $8,097	24 Added 1.18%	2,051 $660,000
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $26,800 - $32,569	-102 Reduced 4.79%	2,027 $633,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $4,570 - $5,517	17 Added 0.8%	2,129 $605,000
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $41,167 - $46,442	161 Added 8.25%	2,112 $608,000
Q3 2023 Nov 15, 2023	BUY	$218.65 - $271.46 $61,440 - $76,280	281 Added 16.83%	1,951 $524,000
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $8,142 - $9,628	38 Added 2.33%	1,670 $370,000
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $14,450 - $17,612	-64 Reduced 3.77%	1,632 $394,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $76,725 - $97,488	335 Added 24.61%	1,696 $445,000
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $24,690 - $27,846	110 Added 8.79%	1,361 $307,000
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $21,225 - $23,620	92 Added 7.94%	1,251 $304,000
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $254,133 - $281,138	1,159 New	1,159 $280,000
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $205,449 - $246,171	-1,180 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$166.7 - $195.41 $196,706 - $230,583	1,180 New	1,180 $217,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Capital, LLC with notifications on news.

Account

Hamilton Capital, LLC Amgen Inc Transaction History